Gentamicin Sulfate
Brand names: Gentamicin Sulfate
At a glance
- Medicare prescriptions, 2024
- 231,168
- Medicare drug cost
- $7.7M
- Average cost per prescription
- $33.43
- Clinicians who prescribed it
- 7,561
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Gentamicin sulfate ophthalmic solution is indicated in the topical treatment of ocular bacterial infections including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis, caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.
From the FDA-approved prescribing information (label dated July 2024). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Dermatology 16.0%
- Nurse Practitioners 13.1%
- Podiatrists 10.5%
- Family Medicine 9.0%
- Internal Medicine 8.5%
- Physician Assistants 8.1%
- Nephrology (Kidney) 6.6%
- Mohs Surgery 6.1%
- Ophthalmology 5.4%
- Urology 3.3%
- General Surgery 2.0%
- Retina Specialist 1.5%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 4% from 2019 to 2024.
Biggest change by state since 2019
- Virginia +19%
- Florida +12%
- Mississippi +6%
- Kentucky +2%
- Ohio +2%
- New York (smallest change) −24%
- Louisiana (smallest change) −22%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.